Hiv/Aids Drugs Market 2019 Size, Share, Growth | Global Industry Research Report, 2026
SKU ID : FBUIN-14602541 | Publishing Date : 01-Aug-2019 | No. of pages : 124
Detailed TOC of Hiv/Aids Drugs Market 2019 Size, Share, Growth | Global Industry Research Report, 2026
TABLE OF CONTENT:1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Epidemiology of HIV/AIDS by Key Countries
4.2. Overview of Pipeline Analysis
4.3. Regulatory Scenario by Key Countries
4.4. Pricing Analysis
4.5. Key Strategies Employed by Market Leaders in Various Regions
4.6. Overview of New Product Launches
5. Global HIV-AIDS Drugs Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Drug Class
5.2.1. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
5.2.2. Integrase Inhibitors
5.2.3. Combination HIV Medicines
5.2.4. Others
5.3. Market Analysis, Insights and Forecast – By Distribution Channel
5.3.1. Hospital Pharmacies
5.3.2. Retail Pharmacies
5.3.3. Online Pharmacies
5.3.4. Others
5.4. Market Analysis, Insights and Forecast – By Region
5.4.1. North America
5.4.2. Europe
5.4.3. Asia Pacific
5.4.4. Rest of World
6. North America HIV-AIDS Drugs Market Analysis, Insights and Forecast, 2015-2026
6.1. Key Findings / Summary
6.2. Market Analysis – By Drug Class
6.2.1. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
6.2.2. Integrase Inhibitors
6.2.3. Combination HIV Medicines
6.2.4. Others
6.3. Market Analysis – By Distribution Channel
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacies
6.3.4. Others
6.4. Market Analysis – By Country
6.4.1. U.S.
6.4.2. Canada
7. Europe HIV-AIDS Drugs Market Analysis, Insights and Forecast, 2015-2026
7.1. Key Findings / Summary
7.2. Market Analysis – By Drug Class
7.2.1. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
7.2.2. Integrase Inhibitors
7.2.3. Combination HIV Medicines
7.2.4. Others
7.3. Market Analysis – By Distribution Channel
7.3.1. Hospital Pharmacies
7.3.2. Retail Pharmacies
7.3.3. Online Pharmacies
7.3.4. Others
7.4. Market Analysis – By Country/ Sub-Region
7.4.1. U.K.
7.4.2. Germany
7.4.3. France
7.4.4. Spain
7.4.5. Italy
7.4.6. Scandinavia
7.4.7. Rest of Europe
8. Asia Pacific HIV-AIDS Drugs Market Analysis, Insights and Forecast, 2015-2026
8.1. Key Findings / Summary
8.2. Market Analysis – By Drug Class
8.2.1. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
8.2.2. Integrase Inhibitors
8.2.3. Combination HIV Medicines
8.2.4. Others
8.3. Market Analysis – By Distribution Channel
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Online Pharmacies
8.3.4. Others
8.4. Market Analysis – By Country/ Sub-Region
8.4.1. Japan
8.4.2. China
8.4.3. India
8.4.4. Australia
8.4.5. Southeast Asia
8.4.6. Rest of Asia Pacific
9. Rest of World HIV-AIDS Drugs Market Analysis, Insights and Forecast, 2015-2026
9.1. Key Findings / Summary
9.2. Market Analysis – By Drug Class
9.2.1. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
9.2.2. Integrase Inhibitors
9.2.3. Combination HIV Medicines
9.2.4. Others
9.3. Market Analysis – By Distribution Channel
9.3.1. Hospital Pharmacies
9.3.2. Retail Pharmacies
9.3.3. Online Pharmacies
9.3.4. Others
10. Competitive Analysis
10.1. Key Industry Developments
10.2. Global Market Share Analysis (2017)
10.3. Competition Dashboard
10.4. Comparative Analysis – Major Players
10.5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
10.5.1. Gilead Sciences, Inc.
10.5.2. ViiV Healthcare
10.5.3. GlaxoSmithKline plc
10.5.4. Merck Sharp & Dohme Corp.
10.5.5. Bristol-Myers Squibb Company
10.5.6. Janssen Pharmaceuticals, Inc.
10.5.7. F. Hoffmann-La Roche Ltd
10.5.8. Theratechnologies Inc.
10.5.9. Mylan Pharmaceuticals Inc.
10.5.10. AbbVie Inc.
11. Strategic Recommendations
Keyplayers in Hiv/Aids Drugs Market 2019 Size, Share, Growth | Global Industry Research Report, 2026
ViiV HealthcareGilead Sciences, Inc.
Merck Sharp & Dohme Corp.
Bristol-Myers Squibb Company
Janssen Pharmaceuticals, Inc.
Theratechnologies Inc.
Mylan Pharmaceuticals Inc.
Genentech, Inc.
AbbVie Inc.